At 12 months, risk factors for persistence of long COVID symptoms included male sex, fever, and taste disorder.

Advanced respiratory support is common in ICU patients with severe viral infections; however, additional infections do not substantially affect 30-day mortality outcomes.

The FDA has approved Tezspire (tezepelumab-ekko) for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with inadequately controlled chronic rhinosinusitis with ...

Three immunologists have won the 2025 Nobel Prize in Physiology or Medicine for uncovering how the immune system prevents itself from attacking the body.

HealthDay News — A robotic-assisted bronchoscope (RAB) can reach very small tumors growing in hard-to-reach parts of the lung, according to a study presented at the annual congress of the European ...

Health officials in several states are battling new measles outbreaks that have forced hundreds of unvaccinated students into quarantine.

Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...

Vaping-related disorder is rare in patients with chronic lung disease but is also associated with a much higher likelihood of ...

Roughly 6 months after starting tezepelumab for severe asthma, many patients reduced OCS dependence and meaningfully improved ...

Race and economic disparities significantly affect lung cancer treatment and outcomes with worse outcomes seen in Black and ...

Most patients with persistent pulmonary symptoms after recovering from mild to moderate COVID-19 infection have normal ...

Patients treated for uncontrolled mild asthma had high symptom burden affecting their daily life but most had no ...